Globe Life Inc. (NYSE:GL – Get Free Report) CEO Frank Svoboda sold 9,379 shares of Globe Life stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total transaction of $1,317,092.97. Following the completion of the sale, the chief executive officer owned 35,868 shares of the company’s stock, valued at $5,036,943.24. This trade represents a 20.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Globe Life Trading Down 1.4%
NYSE:GL traded down $2.00 during trading hours on Wednesday, reaching $138.75. 563,919 shares of the stock were exchanged, compared to its average volume of 617,868. Globe Life Inc. has a twelve month low of $103.88 and a twelve month high of $147.83. The business has a 50-day moving average of $134.07 and a two-hundred day moving average of $132.89. The company has a market capitalization of $11.05 billion, a price-to-earnings ratio of 10.05 and a beta of 0.48. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41.
Globe Life (NYSE:GL – Get Free Report) last posted its quarterly earnings data on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.54 by $0.27. Globe Life had a return on equity of 21.81% and a net margin of 19.36%.The firm had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.52 billion. During the same quarter in the previous year, the business earned $3.44 EPS. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS and its FY 2025 guidance at 14.400-14.600 EPS. On average, equities analysts predict that Globe Life Inc. will post 13.87 EPS for the current year.
Globe Life Announces Dividend
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on GL shares. Piper Sandler restated an “overweight” rating and issued a $167.00 price objective on shares of Globe Life in a report on Friday, November 21st. Cowen restated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Truist Financial upped their price objective on Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a research report on Friday, October 24th. Keefe, Bruyette & Woods lifted their target price on Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a report on Tuesday, October 28th. Finally, Morgan Stanley reissued an “overweight” rating and set a $176.00 target price on shares of Globe Life in a research note on Monday. Nine research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $164.89.
View Our Latest Stock Report on GL
Institutional Investors Weigh In On Globe Life
Several institutional investors have recently modified their holdings of the company. Invesco Ltd. raised its stake in Globe Life by 3.9% in the second quarter. Invesco Ltd. now owns 3,921,439 shares of the company’s stock valued at $487,396,000 after buying an additional 147,644 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Globe Life by 2.9% in the 2nd quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company’s stock valued at $339,875,000 after acquiring an additional 76,995 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Globe Life by 2.9% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,076,232 shares of the company’s stock worth $296,841,000 after acquiring an additional 59,353 shares in the last quarter. AQR Capital Management LLC raised its position in shares of Globe Life by 98.6% during the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after acquiring an additional 696,548 shares in the last quarter. Finally, Norges Bank purchased a new stake in Globe Life during the second quarter worth approximately $157,722,000. 81.61% of the stock is owned by hedge funds and other institutional investors.
About Globe Life
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Stories
- Five stocks we like better than Globe Life
- Health Care Stocks Explained: Why You Might Want to Invest
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- Investing in Construction Stocks
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- Pros And Cons Of Monthly Dividend Stocks
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
